These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7435389)

  • 1. Electrophysiologic effects of disopyramide phosphate on reentrant ventricular arrhythmia in conscious dogs after myocardial infarction.
    Patterson E; Gibson JK; Lucchesi BR
    Am J Cardiol; 1980 Nov; 46(5):792-9. PubMed ID: 7435389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Actions of disopyramide on potential reentrant pathways and ventricular tachyarrhythmias in conscious dogs during the late post-myocardial infarction phase.
    Cobbe SM; Hoffmann E; Ritzenhoff A; Brachmann J; Kübler W; Senges J
    Am J Cardiol; 1984 Jun; 53(11):1712-8. PubMed ID: 6731317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disopyramide plasma and myocardial tissue concentrations as they relate to antiarrhythmic activity.
    Patterson E; Stetson P; Lucchesi BR
    J Cardiovasc Pharmacol; 1979; 1(5):541-50. PubMed ID: 94410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of disopyramide phosphate on ventricular arrhythmias in experimental myocardial infarction.
    Kus T; Sasyniuk BI
    J Pharmacol Exp Ther; 1976 Mar; 196(3):665-75. PubMed ID: 1263118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reentrant arrhythmias in the subacute infarction period. The proarrhythmic effect of flecainide acetate on functional reentrant circuits.
    Restivo M; Yin H; Caref EB; Patel AI; Ndrepepa G; Avitable MJ; Assadi MA; Isber N; el-Sherif N
    Circulation; 1995 Feb; 91(4):1236-46. PubMed ID: 7850964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of E-4031, a new class III antiarrhythmic drug, on reentrant ventricular arrhythmias: comparison with conventional class I drugs.
    Ogawa S; Mitamura H; Katoh H
    Cardiovasc Drugs Ther; 1993 Aug; 7 Suppl 3():621-6. PubMed ID: 8251432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Action of injected disopyramide on ventricular arrhythmias and atrioventricular conduction].
    Vogel M; Desoutter P; Bellanger P; Motté G; Welti JJ
    Arch Mal Coeur Vaiss; 1976 Apr; 69(4):395-406. PubMed ID: 59581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular electrophysiologic changes induced by disopyramide phosphate in normal infarcted hearts.
    Sasyniuk BI; Kus T
    J Int Med Res; 1976; 4(1 Suppl):20-5. PubMed ID: 1026524
    [No Abstract]   [Full Text] [Related]  

  • 9. Electrophysiological effects of disopyramide phosphate during experimental myocardial ischemia.
    Levites R; Anderson GJ
    Am Heart J; 1979 Sep; 98(3):339-44. PubMed ID: 474380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiologic effects of E-4031, a class III antiarrhythmic agent, on re-entrant ventricular arrhythmias in a canine 7-day-old myocardial infarction model.
    Katoh H; Ogawa S; Furuno I; Sato Y; Yoh S; Saeki K; Nakamura Y
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1077-82. PubMed ID: 2359016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of combined administration of verapamil and disopyramide in dogs.
    Lee JT; Davy JM; Kates RE
    J Cardiovasc Pharmacol; 1985; 7(3):501-7. PubMed ID: 2410681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of oral disopyramide phosphate on induction and sustenance of atrioventricular reentrant tachycardia incorporating retrograde accessory pathway conduction.
    Kou HC; Hung JS; Lee YS; Wu D
    Circulation; 1982 Aug; 66(2):454-62. PubMed ID: 6807567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiologic effects of the antiarrhythmic agent disopyramide phosphate.
    Befeler B; Castellanos A; Wells DE; Vagueiro MC; Yeh BK
    Am J Cardiol; 1975 Feb; 35(2):282-7. PubMed ID: 1119389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of lethal ischemic ventricular arrhythmias by the class III agent E4031 in a canine model of previous myocardial infarction.
    Lynch JJ; Heaney LA; Wallace AA; Gehret JR; Selnick HG; Stein RB
    J Cardiovasc Pharmacol; 1990 May; 15(5):764-75. PubMed ID: 1692937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The direct electrophysiologic effects of disopyramide phosphate in the transplanted human heart.
    Bexton RS; Hellestrand KJ; Cory-Pearce R; Spurrell RA; English TA; Camm AJ
    Circulation; 1983 Jan; 67(1):38-45. PubMed ID: 6401173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiology of the enantiomers of disopyramide in dogs.
    Giacomini JC; Giacomini KM; Nelson WL; Harrison DC; Blaschke TF
    J Cardiovasc Pharmacol; 1985; 7(5):884-90. PubMed ID: 2413296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined effect of verapamil and disopyramide on induction of circus movement tachycardia in patients with pre-excitation.
    Matsuda H; Konishi T; Matsuyama E; Tamamura T; Kawai C
    Jpn Circ J; 1981 Oct; 45(10):1138-46. PubMed ID: 7299993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of disopyramide on reperfusion arrhythmias in dogs.
    Chagnac A; Pelleg A; Belhassen B; Lubliner J; Vidné B; Laniado S
    J Cardiovasc Pharmacol; 1982; 4(6):994-8. PubMed ID: 6185794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coupling interval-related effects of class I antiarrhythmic drugs, mexiletine, cibenzoline and disopyramide, on ventricular activation in canine myocardial infarction.
    Hashimoto H; Satoh N; Nakashima M
    Jpn J Pharmacol; 1991 Dec; 57(4):463-72. PubMed ID: 1803064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiarrhythmic and arrhythmogenic actions of methyl lidocaine during the recovery phase after canine myocardial infarction.
    Patterson E; Gibson JK; Lucchesi BR
    Pharmacology; 1988; 36(2):73-83. PubMed ID: 3353442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.